Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smarter catheter cut infections and blockages?

NCT ID NCT07782762

Disease control Sponsor: Nowwell AS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This study tests whether a new type of Foley catheter, called NowCath, can reduce urinary tract infections and blockages in people who need a long-term indwelling catheter. The NowCath catheter has extra drainage holes and a soft silicone cover that may improve bladder emptying and reduce irritation. In a crossover design, 160 adults will use both the NowCath and a standard catheter for 12 weeks each, and researchers will compare the number of catheter changes needed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NowCath Foley catheter, an all-silicone indwelling urinary catheter with extra drainage eyelets and a silicone skirt to reduce bladder wall suction
What this could lead to
If effective, this catheter could reduce the frequency of urinary tract infections and blockages, improving quality of life and reducing healthcare needs for long-term catheter users.
What could go wrong
The trial is relatively small and early, and results may not apply to all catheter users. The new design might not significantly outperform the standard catheter, and there could be unforeseen complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older * Indwelling urethral or suprapubic Foley catheter in place for at least 28 days prior to enrolment * Expected need for continued indwelling catheterization for at least 6 months * No systemic antibiotic treatment for CAUTI within 48 hours prior to enrolment * Written informed consent provided by the participant * Receiving community nursing care from Ikast-Brande or Holstebro municipalities (or otherwise cared for by their services) Exclusion Criteria: * Known allergy or hypersensitivity to silicone or glycerin * Straight-tip catheterization considered clinically unsuitable * Planned continuation of prophylactic antibiotics for frequent CAUTI * Ureteric stents in place or planned genito-urinary procedures during the study period * Pregnancy, lactation, or planned pregnancy during the study period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Catheter-associated urinary tract infection are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Catheter-Related Infections

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Catheter-associated urinary tract infection Catheter-related infections Urinary catheterization Urinary catheters

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gødstrup Hospital, Department of Medicine

    RECRUITING

    Herning, 7400, Denmark

  • Holstebro Municipality

    RECRUITING

    Holstebro, 7500, Denmark

  • Ikast-Brande Municipality

    RECRUITING

    Ikast, 7430, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.